Bunkerhill ECG-EF vs FibriCheck

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Bunkerhill Health
VS
by FibriCheck

AI Verdict

Bunkerhill ECG-EF is designed for clinicians to identify patients at risk for heart failure by analyzing routine 12-lead ECGs for reduced left ventricular ejection fraction. FibriCheck, conversely, is a patient-facing mobile application that uses smartphone camera-based PPG technology to monitor heart rhythm for the detection and ongoing management of arrhythmias. While both leverage AI in cardiology, Bunkerhill focuses on diagnostic aid for heart failure risk from clinical data, whereas FibriCheck provides remote monitoring for rhythm disorders.

Choose Bunkerhill ECG-EF if…

Choose Bunkerhill ECG-EF if your clinical practice or hospital system needs to efficiently screen a large volume of patients for early signs of heart failure risk using existing 12-lead ECG data. This tool is ideal for integrating into automated clinical workflows to identify reduced left ventricular ejection fraction (LVEF) non-invasively and rapidly, aiding in proactive patient management within a traditional healthcare setting.

View Bunkerhill ECG-EF →

Choose FibriCheck if…

Choose FibriCheck if you are a patient seeking a convenient, smartphone-based solution for regular heart rhythm monitoring to detect arrhythmias, or if you are a healthcare provider looking to implement a remote monitoring program for patients at risk of or living with arrhythmias. This app empowers patients with self-monitoring capabilities while providing clinicians with a portal to oversee and manage patient cardiac health remotely.

View FibriCheck →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Bunkerhill ECG-EF FibriCheck
Pricing Contact sales for pricing details. Subscription-based, with options for monthly or annual payments. prices vary by region and may be partly or fully covered by insurance or employer.
Deployment Cloud-native platform (Carebricks) that integrates with existing health system infrastructure like EHRs. Cloud-based (private cloud).
FDA Status Yes AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Bunkerhill ECG-EF

Tool A (Bunkerhill ECG-EF) integrates seamlessly with existing EHRs and clinical archives, analyzing routine ECG data within established clinical workflows. This minimizes disruption and reduces the learning curve for healthcare providers. Tool B (FibriCheck), while user-friendly for patients, introduces a separate mobile application and a professional portal for clinicians to manage, which may be less integrated into daily clinical practice.

Clinical Value

Bunkerhill ECG-EF

Tool A (Bunkerhill ECG-EF) offers early identification of reduced Left Ventricular Ejection Fraction (LVEF) from routine 12-lead ECGs, a critical marker for heart failure risk, enabling proactive screening at scale. This non-invasive and accessible tool can lead to earlier intervention and improved patient outcomes for a major health condition. Tool B (FibriCheck) provides valuable detection and monitoring of arrhythmias like AFib, empowering patients and aiding in stroke prevention, but Tool A's ability to leverage a ubiquitous test for early heart failure detection has broad preventative implications.

Pricing & Value

FibriCheck

Tool B (FibriCheck) offers transparent and detailed pricing structures for both end-users and healthcare providers, including subscription models and per-measurement options. This clarity allows for easier budgeting and a more straightforward assessment of its value proposition. Tool A (Bunkerhill ECG-EF) requires direct contact for pricing, which limits transparency and makes it harder for potential customers to evaluate its cost-effectiveness upfront.

Enterprise Readiness

Bunkerhill ECG-EF

Tool A (Bunkerhill ECG-EF) explicitly states FDA clearance, HIPAA compliance, BAA availability, and 'seamless integration with EHRs and clinical archives' as part of its Carebricks platform, which supports automated clinical workflows. This demonstrates a robust strategy for enterprise-level deployment and operationalization. While Tool B (FibriCheck) is also medically certified and HIPAA compliant, its enterprise integration capabilities, particularly with EHRs, are less explicitly emphasized compared to Tool A's comprehensive platform approach.

Innovation

Bunkerhill ECG-EF

Tool A (Bunkerhill ECG-EF) leverages 'Generative AI for clinical reasoning and action' to extract a critical new biomarker (LVEF) from standard ECGs, representing a significant advancement in deriving novel insights from existing data. Its Carebricks platform aims to automate subsequent clinical actions, indicating a broader, more transformative application of AI. Tool B (FibriCheck) innovates by providing medically certified smartphone-based PPG for heart rhythm monitoring, enhancing patient accessibility, but the core technology is becoming more common.

Support & Docs

FibriCheck

Tool B (FibriCheck) clearly outlines comprehensive user support, including user manuals, a help center with FAQs, direct support via email and phone, and tailored onboarding for healthcare providers. They also provide service documents in accessible formats. In contrast, Tool A (Bunkerhill ECG-EF) does not explicitly detail its user-facing support channels, comprehensive documentation, or training programs in the provided information or web searches.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Bunkerhill ECG-EF FibriCheck
Name Bunkerhill ECG-EF FibriCheck
Company BunkerHill Health Qompium nv
Description FDA-cleared artificial intelligence algorithm by BunkerHill Health that detects reduced left ventricular ejection fraction (LVEF u2264 40%) from routine 12-lead electrocardiograms (ECGs), aiding in the early identification of patients at risk for heart failure. Medically certified app that helps patients monitor their heart rhythm to detect and monitor arrhythmias using just their smartphone.
Primary Detection Focus Reduced Left Ventricular Ejection Fraction (LVEF u2264 40%) Arrhythmias (e.g., Atrial Fibrillation)
Data Input Method Routine 12-lead ECG data Smartphone camera-based PPG technology
Key Feature Example AI algorithm to detect reduced Left Ventricular Ejection Fraction (LVEF u2264 40%) Smartphone camera-based PPG technology for heart rhythm measurement

Videos

Demos, reviews, and walkthroughs featuring Bunkerhill ECG-EF and FibriCheck.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Bunkerhill ECG-EF is an AI algorithm that detects reduced left ventricular ejection fraction (LVEF u2264 40%) from routine 12-lead ECGs, aiding in the early identification of patients at risk for heart failure. FibriCheck is a medically certified app that helps patients monitor their heart rhythm to detect and monitor arrhythmias, such as Atrial Fibrillation (AFib), using their smartphone.
Bunkerhill ECG-EF analyzes data from routine 12-lead electrocardiograms (ECGs). FibriCheck uses smartphone camera-based photoplethysmography (PPG) technology to measure heart rhythm.
Bunkerhill ECG-EF integrates seamlessly with Electronic Health Records (EHRs) and ECG Management Systems (EMS), supporting automated clinical workflows. FibriCheck is a cloud-based digital application with a patient-facing mobile app and a healthcare professional portal for patient monitoring, and it offers API-based integration into existing EHRs and RPM platforms.
Bunkerhill ECG-EF is primarily used by physicians and healthcare systems to aid in the early identification of patients at risk for heart failure, supporting automated clinical reasoning and action. FibriCheck is a patient-facing mobile application for self-monitoring of heart rhythm, with a healthcare professional portal for providers to review patient data and manage alerts.
AI Tool Finder
AI-powered search. Results may not be comprehensive.